Masimo Corporation (0JZ2.L)

USD 148.31

(-1.24%)

Long Term Debt Summary of Masimo Corporation

  • Masimo Corporation's latest annual long term debt in 2023 was 871.7 Million USD , down -7.42% from previous year.
  • Masimo Corporation's latest quarterly long term debt in 2024 Q1 was 902.9 Million USD , down -3.48% from previous quarter.
  • Masimo Corporation reported annual long term debt of 941.6 Million USD in 2022, up 3481.59% from previous year.
  • Masimo Corporation reported annual long term debt of 26.29 Million USD in 2021, down -7.34% from previous year.
  • Masimo Corporation reported quarterly long term debt of 902.9 Million USD for 2024 Q1, down -3.48% from previous quarter.
  • Masimo Corporation reported quarterly long term debt of 733.2 Million USD for 2024 Q3, down -1.78% from previous quarter.

Annual Long Term Debt Chart of Masimo Corporation (2023 - 1998)

Historical Annual Long Term Debt of Masimo Corporation (2023 - 1998)

Year Long Term Debt Long Term Debt Growth
2023 871.7 Million USD -7.42%
2022 941.6 Million USD 3481.59%
2021 26.29 Million USD -7.34%
2020 28.37 Million USD 79.19%
2019 15.83 Million USD -77.33%
2018 69.85 Million USD 807.01%
2017 -9.88 Million USD -2805.88%
2016 -340 Thousand USD -100.18%
2015 185.07 Million USD 47.03%
2014 125.87 Million USD 55842.67%
2013 225 Thousand USD -88.95%
2012 2.03 Million USD 2652.7%
2011 74 Thousand USD -39.34%
2010 122 Thousand USD -28.65%
2009 171 Thousand USD 8.92%
2008 157 Thousand USD -99.19%
2007 19.5 Million USD 44.31%
2006 13.51 Million USD -36.59%
2005 21.31 Million USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
1999 1.6 Million USD 60.0%
1998 1 Million USD 0.0%

Peer Long Term Debt Comparison of Masimo Corporation

Name Long Term Debt Long Term Debt Difference
Phreesia, Inc. 2.04 Million USD -42442.704%
Accuray Incorporated 164.4 Million USD -430.231%
Align Technology, Inc. 96.96 Million USD -798.956%
Elevance Health Inc. 23.24 Billion USD 96.25%
AxoGen, Inc. 46.6 Million USD -1770.48%
Boston Scientific Corporation 8.56 Billion USD 89.824%
CVS Health Corporation 74.67 Billion USD 98.833%
Cardinal Health, Inc. 4.58 Billion USD 80.98%
Centene Corporation 17.69 Billion USD 95.075%
DaVita Inc. 8.05 Billion USD 89.173%
HCA Healthcare, Inc. 36.62 Billion USD 97.62%
Hologic, Inc. 2.49 Billion USD 65.092%
Humana Inc. 10.21 Billion USD 91.465%
IDEXX Laboratories, Inc. 622.88 Million USD -39.946%
Laboratory Corporation of America Holdings 4.05 Billion USD 78.501%
McKesson Corporation 5.45 Billion USD 84.008%
Patterson Companies, Inc. 328.91 Million USD -165.026%
Quest Diagnostics Incorporated 4.41 Billion USD 80.234%
ResMed Inc. 697.31 Million USD -25.008%
Henry Schein, Inc. 1.93 Billion USD 54.904%
Teladoc Health, Inc. 1.58 Billion USD 44.882%
Universal Health Services, Inc. 4.71 Billion USD 81.517%
Veeva Systems Inc. 46.44 Million USD -1777.005%
Baxter International Inc. 11.06 Billion USD 92.121%
Becton, Dickinson and Company 14.73 Billion USD 94.085%
Intuitive Surgical, Inc. -82.1 Million USD 1161.754%
Danaher Corporation 17.66 Billion USD 95.064%
Stryker Corporation 10.9 Billion USD 92.003%
Medtronic plc 23.87 Billion USD 96.349%